Lindsey Rolfe Clovis Oncology, Inc. (CLVS) insider trading activity

CLVS Quotes by TradingView

Lindsey Rolfe is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 113,691 shares of CLVS, which is worth approximately $10,232. The most recent transaction as insider was on May 01, 2021, when has been sold 8,374 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K
0% 3M change
0% 12M change
Total Value Held $10,232

Lindsey Rolfe Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2021
BUY
Exercise of conversion of derivative security
-
8,374 Added 9.96%
75,723 Common Stock
Mar 02 2021
SELL
Open market or private sale
$4,158 $6.29 p/Share
661 Reduced 0.94%
69,364 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
-
1,313 Added 1.85%
69,710 Common Stock
Feb 02 2021
SELL
Open market or private sale
$94,150 $7.97 p/Share
11,813 Reduced 14.67%
68,712 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
-
22,250 Added 22.08%
78,534 Common Stock
Dec 21 2020
SELL
Open market or private sale
$9,815 $5.68 p/Share
1,728 Reduced 2.88%
58,275 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
-
3,438 Added 5.42%
60,003 Common Stock
Dec 15 2020
SELL
Payment of exercise price or tax liability
$72,322 $5.11 p/Share
14,153 Reduced 20.01%
56,565 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$56,550 $3.28 p/Share
17,241 Added 19.6%
70,718 Common Stock
Dec 03 2020
SELL
Open market or private sale
$3,232 $4.89 p/Share
661 Reduced 1.22%
53,477 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
-
1,312 Added 2.38%
53,823 Common Stock
Nov 03 2020
SELL
Open market or private sale
$9,466 $4.93 p/Share
1,920 Reduced 3.51%
52,826 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
-
3,749 Added 6.41%
54,746 Common Stock

Also insider at

PBAXU
PHOENIX BIOTECH ACQUISITION CORP. Financial Services
Director
BCEL
Atreca, Inc. Healthcare
Director
LR

Lindsey Rolfe

Officer
Boulder, CO

Track Institutional and Insider Activities on CLVS

Follow Clovis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

News

Receive news related to Clovis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLVS